Investigação genética em pacientes com cardiomiopatia dilatada / Genetic screening in dilated cardiomyopathy patients

AUTOR(ES)

Diogo Gonçalves Biagi dos Santos

DATA DE PUBLICAÇÃO

2011

RESUMO

Introduction: Dilated Cardiomyopathy is one of the leading causes of heart failure with high morbidity e mortality. Already known genetic alterations explain little percentage of cases suggesting that other genes would be related with the disease. Four candidates genes previously related with other cardiac diseases were selected for the project to verify a possible relationship with dilated cardiomyopathy. Objectives: Evaluate the presence and frequency of genetic alterations in ACTC1, FKBP1A, FKBP1B and CSRP3 genes in dilated cardiomyopathy patients of São Paulo Heart Institute (Incor, FMUSP). To investigate for genotype/phenotype correlations and to study functional alterations triggered by the found mutations. Methods: DNA samples from 186 patients with dilated cardiomyopathy were selected from the Incor DNA bank and genetically screened for alterations in the selected genes. Results and Discussion: Nine new genetic variants were found. Five of them were present in the control population, thus being excluded as disease causative. Three of them were not present in the control population; however, bioinformatics analysis evaluated the alterations having a low risk of being causatives. One alteration in CSRP3 gene that resulted in amino-acid change was not present in control population and exhibit indicative data of disease causing mutation. Analysis of patient heart showed no difference from some disease mechanisms described in literature. Conclusions: There are no evidences that alterations in ACTC1, FKBP1A and FKBP1B genes would associated with disease development. Alteration in CSRP3 gene is also capable to cause dilated cardiomyopathy s

ASSUNTO(S)

cardiomiopatia dilatada/genética dilated cardiomyopathy/genetics gene genes heart failure insuficiência cardíaca mutação mutation

Documentos Relacionados

• Mecanismos celulares e biomoleculares na cardiomiopatia dilatada
• Survival study and assessment of prognostic factors in dogs with idiopathic dilated cardiomyopathy
• Clinical avaliation of dogs with dilated cardiomyopathy (DCM) treated by carvedilol
• Valor prognóstico da reserva de fluxo coronário e miocárdico obtida pela ecocardiografia contrastada em pacientes com cardiomiopatia dilatada de origem não isquêmica
• Escore Albumina-Bilirrubina para Predizer Desfechos em Pacientes com Cardiomiopatia Dilatada Idiopática